Interface display method, system, central station, readable storage medium and program product

Abstract

This application relates to an interface display method, system, central station, readable storage medium, and program product, applied to a blood glucose monitoring system. The method includes: responding to a user-inputted multi-bed observation mode command, controlling the display interface of the blood glucose monitoring system to display multiple display segments; after each display segment completes device binding operations with a blood glucose monitoring device and an insulin infusion device, controlling the information display area in the display segment to display blood glucose measurement values ​​collected during the operation of the blood glucose monitoring device and insulin infusion information implemented during the operation of the insulin infusion device; in the event that at least one abnormal event is detected during the operation of the blood glucose monitoring device and / or insulin infusion device, obtaining alarm reminder information to be displayed according to abnormal event alarm rules; and controlling the alarm display area in the display segment to display the alarm reminder information. This method reduces the maintenance workload caused by the dispersion of devices and data by integrating the management of different devices.

Description

Technical Field

[0001] This application relates to the field of interface display technology, and in particular to an interface display method, system, central station, computer-readable storage medium, and computer program product. Background Technology

[0002] Diabetes is a disease caused by excessively high blood sugar levels due to insulin deficiency, insulin resistance, or a decreased insulin secretion rate, leading to various health problems. It is typically treated with an insulin pump. Specifically, each user is equipped with an insulin pump and a blood glucose monitoring device. The blood glucose monitoring device tracks and monitors changes in the patient's blood glucose levels, and the insulin infusion device is adjusted based on these changes to manage the user's blood glucose levels.

[0003] Currently, continuous glucose monitoring systems are used on client-side devices, sending blood glucose levels to mobile terminals for users to view and manage the normal operation of blood glucose monitoring and insulin infusion devices. However, for hospital staff, centrally managing devices used by different patients is a very complex and challenging task. If abnormal alarm events occur during device operation and staff fail to handle them promptly, it can lead to risks in blood glucose management. Summary of the Invention

[0004] Therefore, it is necessary to provide an interface display method, system, central station, computer-readable storage medium, and computer program product to address the technical problems of low efficiency and high maintenance costs of the above-mentioned equipment management methods.

[0005] Firstly, this application provides a method for displaying an interface.

[0006] The method is applied to a blood glucose monitoring system, wherein the blood glucose monitoring system establishes communication connections with a blood glucose monitoring device and an insulin infusion device, respectively; the method includes:

[0007] In response to the user's input command for a multi-bed observation mode, the display interface of the blood glucose monitoring system is controlled to display multiple display segments;

[0008] After each display segment completes the device binding operation with the blood glucose monitoring device and the insulin infusion device, the information display area in the display segment is controlled to display the blood glucose measurement values ​​collected during the operation of the blood glucose monitoring device and the insulin infusion information implemented during the operation of the insulin infusion device;

[0009] Monitor whether at least one abnormal event occurs during the operation of the blood glucose monitoring device and / or insulin infusion device;

[0010] In the event of at least one abnormal event, obtain the alarm notification information to be displayed according to the abnormal event alarm rules;

[0011] The alarm display area in the display section is controlled to display the alarm reminder information.

[0012] In one embodiment, obtaining alarm notification information according to abnormal event alarm rules includes:

[0013] The system identifies whether an abnormal event has occurred based on the safety operation rules of the blood glucose monitoring device and / or insulin infusion device; if an abnormal event is confirmed, the alarm display priority of the abnormal event is determined according to the abnormal event alarm rules set in the safety operation rules.

[0014] Based on the alarm display priority, the highest priority target abnormal event is displayed;

[0015] Obtain alarm notifications that match the target abnormal event from the safety operation rules.

[0016] In one embodiment, the alarm display priority of abnormal events is determined according to the abnormal event alarm rules set by the safe operation rules, including:

[0017] Establish alarm levels and priority numbers for abnormal events according to safe operation rules;

[0018] Identify the event content of the abnormal event, and obtain the alarm level and priority number of the abnormal event based on the event content;

[0019] The alarm display priority of abnormal events is determined based on the alarm level and the priority number.

[0020] In one embodiment, after controlling the display of the highest priority target abnormal event according to the alarm display priority, the method further includes:

[0021] In response to the alarm reset operation performed by the user, an alarm reset operation is performed on the highest priority target abnormal event;

[0022] After the reset is complete, the alarm notification information for the second highest priority abnormal event will be displayed according to the alarm display priority.

[0023] In one embodiment, the method further includes:

[0024] If the display type of the alarm notification information for the target abnormal event is the immediate display type, or the alarm display priority of the target abnormal event is not lower than the alarm display priority of the currently displayed abnormal event, then the alarm notification information for the currently displayed abnormal event is stopped, and the alarm notification information for the target abnormal event is displayed.

[0025] In one embodiment, after the alarm display area in the control display segment displays the alarm reminder information, the method further includes:

[0026] In response to the user's single-bed observation command for the display section, the display interface is controlled to display the single-bed observation interface;

[0027] In response to the statistical analysis operation triggered by the user, the single-bed observation interface is controlled to display statistical information on the patient's blood glucose measurement and / or insulin infusion information.

[0028] In one embodiment, the method further includes:

[0029] In response to the statistical analysis operation triggered by the user, multiple time period entries are displayed;

[0030] Based on the user's selection instruction for the target time period among the multiple time period entries, the single-bed observation interface is controlled to display statistical information on the patient's blood glucose measurement value and / or insulin infusion information within the time period corresponding to the target time period entry.

[0031] Secondly, this application also provides a blood glucose monitoring system, including a blood glucose monitoring device, an insulin infusion device, a display device, a communication unit, and at least one processor, the processor being configured to execute executable instructions on a memory to perform the following steps:

[0032] In response to the user's input command for multi-bed observation mode, the display interface of the blood glucose monitoring system is controlled to display multiple display segments;

[0033] After each display segment completes the device binding operation with the blood glucose monitoring device and the insulin infusion device, the information display area in the display segment is controlled to display the blood glucose measurement values ​​collected during the operation of the blood glucose monitoring device and the insulin infusion information implemented during the operation of the insulin infusion device;

[0034] Monitor whether at least one abnormal event occurs during the operation of the blood glucose monitoring device and / or insulin infusion device;

[0035] In the event of at least one abnormal event, obtain the alarm notification information to be displayed according to the abnormal event alarm rules;

[0036] The alarm display area in the display section is controlled to display the alarm reminder information.

[0037] Thirdly, this application also provides a central station. It includes a display device, a communication unit, and at least one processor, the processor being configured to execute executable instructions in memory to perform the following steps:

[0038] In response to the user's input command for multi-bed observation mode, the display interface of the blood glucose monitoring system is controlled to display multiple display segments;

[0039] After each display segment completes the device binding operation with the blood glucose monitoring device and the insulin infusion device, the information display area in the display segment is controlled to display the blood glucose measurement values ​​collected during the operation of the blood glucose monitoring device and the insulin infusion information implemented during the operation of the insulin infusion device;

[0040] Monitor whether at least one abnormal event occurs during the operation of the blood glucose monitoring device and / or insulin infusion device;

[0041] In the event of at least one abnormal event, obtain the alarm notification information to be displayed according to the abnormal event alarm rules;

[0042] The alarm display area in the display section is controlled to display the alarm reminder information.

[0043] Fourthly, this application also provides a computer-readable storage medium. The computer-readable storage medium stores a computer program thereon, which, when executed by a processor, performs the following steps:

[0044] In response to the user's input command for multi-bed observation mode, the display interface of the blood glucose monitoring system is controlled to display multiple display segments;

[0045] After each display segment completes the device binding operation with the blood glucose monitoring device and the insulin infusion device, the information display area in the display segment is controlled to display the blood glucose measurement values ​​collected during the operation of the blood glucose monitoring device and the insulin infusion information implemented during the operation of the insulin infusion device;

[0046] Monitor whether at least one abnormal event occurs during the operation of the blood glucose monitoring device and / or insulin infusion device;

[0047] In the event of at least one abnormal event, obtain the alarm notification information to be displayed according to the abnormal event alarm rules;

[0048] The alarm display area in the display section is controlled to display the alarm reminder information.

[0049] Fifthly, this application also provides a computer program product. The computer program product includes a computer program that, when executed by a processor, performs the following steps:

[0050] In response to the user's input command for multi-bed observation mode, the display interface of the blood glucose monitoring system is controlled to display multiple display segments;

[0051] After each display segment completes the device binding operation with the blood glucose monitoring device and the insulin infusion device, the information display area in the display segment is controlled to display the blood glucose measurement values ​​collected during the operation of the blood glucose monitoring device and the insulin infusion information implemented during the operation of the insulin infusion device;

[0052] Monitor whether at least one abnormal event occurs during the operation of the blood glucose monitoring device and / or insulin infusion device;

[0053] In the event of at least one abnormal event, obtain the alarm notification information to be displayed according to the abnormal event alarm rules;

[0054] The alarm display area in the display section is controlled to display the alarm reminder information.

[0055] The aforementioned interface display method, system, central station, storage medium, and computer program products construct a blood glucose monitoring system. The web-based display interface is divided into multiple display segments, each linked to a patient's blood glucose monitoring device and insulin infusion device to display that patient's blood glucose monitoring values ​​and insulin infusion information. This enables centralized management of all patient data, allowing for the analysis and processing of massive amounts of data, effectively reducing manual workload and improving data processing efficiency. By monitoring for at least one abnormal event during the operation of the blood glucose monitoring device and / or insulin infusion device; in the event of at least one abnormal event, alarm reminders are obtained according to the abnormal event alarm rules; and the alarm display area in the display segment is controlled to display the alarm reminders, enabling timely identification of abnormal patient blood glucose levels and improving patient monitoring efficiency. Furthermore, by integrating the management of different devices, the maintenance workload caused by scattered devices and data is reduced, management costs are lowered, and it can support multiple patients accessing simultaneously and easily expand to new devices and patients without redesigning the system architecture, demonstrating strong adaptability. Moreover, by receiving and displaying each patient's blood glucose monitoring values ​​and insulin infusion information in real time, medical staff can promptly understand the patient's condition. This integrated, real-time blood glucose monitoring system not only improves the efficiency and accuracy of blood glucose management for diabetic patients, but also reduces system maintenance costs and improves the patient experience, thus effectively solving the problems of low management efficiency and high maintenance costs faced by existing technologies. Attached Figure Description

[0056] Figure 1 This is a schematic diagram of a system architecture used to implement the interface display method in one embodiment;

[0057] Figure 2 This is a flowchart illustrating the interface display method in one embodiment;

[0058] Figure 3This is a schematic diagram of the display interface of a blood glucose monitoring system in one embodiment;

[0059] Figure 4 This is a flowchart illustrating the error message display steps in one embodiment;

[0060] Figure 5 This is a schematic diagram of the interface of a single display segment in one embodiment;

[0061] Figure 6 This is a structural block diagram of a blood glucose monitoring system in one embodiment;

[0062] Figure 7 This is an internal structural diagram of a computer device in one embodiment. Detailed Implementation

[0063] To make the objectives, technical solutions, and advantages of this application clearer, the following detailed description is provided in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are merely illustrative and not intended to limit the scope of this application.

[0064] It should be noted that the terms "first," "second," etc., in the specification, claims, and accompanying drawings of this application are used to distinguish similar objects and are not necessarily used to describe a specific order or sequence. It should be understood that such data can be interchanged where appropriate so that the embodiments of this application described herein can be implemented in sequences other than those illustrated or described herein.

[0065] To address the shortcomings of traditional diabetes diagnosis and treatment equipment management methods, such as inadequacy, low efficiency, and high maintenance costs, this application proposes a novel blood glucose monitoring method. This method collects data from insulin infusion devices and blood glucose monitoring devices (such as continuous glucose monitoring systems, CGM) to a cloud platform, and uses artificial intelligence (AI) algorithms to manage and diagnose device status, analyze the effectiveness of diabetes treatment, and analyze user habits and behaviors, thereby improving management efficiency and reducing equipment maintenance costs.

[0066] In one implementation, the blood glucose monitoring system can establish communication connections with a blood glucose monitoring device and an insulin infusion device to display blood glucose measurements collected during operation of the blood glucose monitoring device and insulin infusion information implemented during operation of the insulin infusion device.

[0067] In another implementation, such as Figure 1The illustrated blood glucose monitoring system can establish communication connections with blood glucose monitoring devices and insulin infusion devices via a terminal. The terminal collects treatment data and device data from the insulin infusion device within the diabetes treatment equipment, as well as user blood glucose data collected by the blood glucose monitoring device and the device's own device data. After collecting data from different patients, the terminal uploads it to a cloud platform, where it is centrally processed by the blood glucose monitoring system deployed on the cloud platform and displayed centrally on the front-end interface.

[0068] In one embodiment, such as Figure 2 As shown, an interface display method is provided. This embodiment illustrates the application of this method to a blood glucose monitoring system. The blood glucose monitoring system includes a web-based display interface, which is divided into multiple display segments, each associated with a patient. (Reference) Figure 3 This is a schematic diagram of the display interface of a blood glucose monitoring system according to one embodiment, as shown below. Figure 3 As shown, the display interface includes multiple display sections 310, each of which can be set to display the blood glucose status of a patient.

[0069] In this embodiment, the method includes the following steps:

[0070] Step S210: In response to the user's input command for multi-bed observation mode, control the display interface of the blood glucose monitoring system to display multiple display segments.

[0071] Specifically, the blood glucose monitoring system receives user input commands for a multi-bed observation mode and initiates interface adjustments. It controls the system's display interface, dividing it into multiple display segments, each with independent function, capable of displaying blood glucose data for associated patients, facilitating the observation of blood glucose status for multiple patients.

[0072] Step S220: After completing the device binding operation with the blood glucose monitoring device and insulin infusion device in each display segment, control the information display area in the display segment to display the blood glucose measurement value collected during the operation of the blood glucose monitoring device and the insulin infusion information implemented during the operation of the insulin infusion device.

[0073] Specifically, each patient has a corresponding insulin infusion device and blood glucose monitoring device. Insulin is infused into the patient through the insulin infusion device to control blood glucose levels, while the blood glucose monitoring device monitors the patient's real-time blood glucose information. For each display segment, a connection can be established between that display segment and a patient's blood glucose monitoring device and insulin infusion device through a device binding operation. This allows the device to receive blood glucose measurements collected during the operation of the patient's blood glucose monitoring device and insulin infusion information implemented during the operation of the insulin infusion device. Upon receiving the blood glucose monitoring values ​​and insulin infusion information, this information can be displayed in the information display area corresponding to that patient's display segment.

[0074] More specifically, the system can display the patient's blood glucose changes in a first area of ​​the information display area based on real-time blood glucose monitoring values, and display the patient's insulin infusion records in a second area of ​​the information display area based on insulin infusion information. Specifically, within each display segment's information display area, a first area for displaying blood glucose changes and a second area for displaying insulin infusion records can be pre-defined. Upon receiving the patient's blood glucose monitoring value and insulin infusion information for any display segment, the blood glucose monitoring value can be displayed in the first area, and the insulin infusion information in the second area. Thus, in the first area, the patient's blood glucose changes can be reflected based on real-time blood glucose monitoring values ​​at various times, while in the second area, each insulin infusion record can form the patient's insulin infusion record. This allows for convenient blood glucose management based on the information from both the first and second areas.

[0075] In some embodiments, the patient's blood glucose changes are displayed as a curve in a first area. In a second area, the patient's insulin infusion record is displayed as a graph (such as a bar chart, list, etc.), for example, with time marked on the horizontal axis and insulin dose displayed on the vertical axis, and the insulin dose for each infusion may be labeled.

[0076] In one implementation, when a user hovers over a data point on the chart, detailed information (such as blood glucose levels or insulin infusions) can be displayed, and different time ranges can be selected to view historical data.

[0077] With graphs, healthcare professionals and patients can quickly understand blood glucose trends, enabling better daily management; graphical insulin infusion records make monitoring dosage and timing simpler, making it easier to adjust treatment plans.

[0078] Step S230: Monitor whether at least one abnormal event occurs during the operation of the blood glucose monitoring device and / or insulin infusion device.

[0079] Specifically, during the operation of the blood glucose monitoring device and / or insulin infusion device, the system continuously monitors for preset abnormal events, including malfunctions of the blood glucose monitoring device and malfunctions of the insulin infusion device.

[0080] For example, abnormal events of blood glucose monitoring devices may include hypoglycemia, hyperglycemia, rapid rise in blood glucose, rapid drop in blood glucose, loss of blood glucose data, abnormal blood glucose data, sensor malfunction, and expired sensor. Abnormalities of insulin infusion devices may include excessively strong magnetic field around the pump, depleted pump power, depleted pump medication, blocked pump tubing, low battery, minimum dosage alarm status and value, and pump connection failure.

[0081] Step S240: In the event of at least one abnormal event, obtain the alarm reminder information to be displayed according to the abnormal event alarm rules.

[0082] Specifically, the system can issue an alarm when any abnormal event is detected during the operation of the blood glucose monitoring device and / or insulin infusion device. It can be understood that, to differentiate between different abnormal events, priorities can be assigned to them, and corresponding alarm messages can be generated based on the priority of the abnormal event.

[0083] Step S250: Control the alarm display area in the display section to display alarm reminder information.

[0084] Specifically, in one embodiment, after determining the alarm notification information of the abnormal event, the alarm notification information can be displayed in a preset alarm display area in the display segment, for example, in the upper right corner of the display segment.

[0085] In some embodiments, changes in blood glucose monitoring values ​​can also be alerted by displaying a blood glucose change curve in the first area of ​​the information display area. The patient's blood glucose changes are displayed as a curve in the first area of ​​the information display area. For example, a blood glucose change curve can be dynamically drawn using a chart library in the first area to display blood glucose data at different time points, intuitively reflecting the patient's blood glucose changes. The horizontal axis of the blood glucose change curve is set to time, and the vertical axis is set to blood glucose level. Upper and lower intervals (warning lines) of the normal blood glucose range can be marked, and blood glucose curves exceeding the normal range are marked. For example, different colored lines or backgrounds can be used to display the exceeding areas so that the monitor can notice them promptly. Furthermore, when a patient's blood glucose data is detected to be continuously exceeding the normal range, the system can automatically alert medical staff (e.g., by sending SMS, email, system notification, etc.).

[0086] In the aforementioned interface display method, a blood glucose monitoring system is constructed, and the web-based display interface is divided into multiple display sections. Each display section is bound to a patient's blood glucose monitoring device and insulin infusion device to display the patient's blood glucose monitoring values ​​and insulin infusion information. This achieves centralized management of all patient data, allowing for the analysis and processing of massive amounts of data, effectively reducing manual workload and improving data processing efficiency. By monitoring whether at least one abnormal event occurs during the operation of the blood glucose monitoring device and / or insulin infusion device; in the event of at least one abnormal event, alarm reminder information to be displayed is obtained according to the abnormal event alarm rules; and the alarm display area in the display section is controlled to display the alarm reminder information, enabling timely identification of abnormal blood glucose levels in patients and improving patient monitoring efficiency. Furthermore, by integrating the management of different devices, the maintenance workload caused by the dispersion of devices and data is reduced, management costs are lowered, and it can support multiple patients accessing simultaneously and easily expand to new devices and patients without redesigning the system architecture, demonstrating strong adaptability. Moreover, by receiving and displaying each patient's blood glucose monitoring values ​​and insulin infusion information in real time, medical staff can promptly understand the patient's condition. This integrated, real-time blood glucose monitoring system not only improves the efficiency and accuracy of blood glucose management for diabetic patients, but also reduces system maintenance costs and improves the patient experience, thus effectively solving the problems of low management efficiency and high maintenance costs faced by existing technologies.

[0087] In an exemplary embodiment, step S240 obtains alarm reminder information according to the abnormal event alarm rules, including: identifying whether an abnormal event has occurred according to the safety operation rules of the blood glucose monitoring device and / or insulin infusion device; if an abnormal event is confirmed to have occurred, determining the alarm display priority of the abnormal event according to the abnormal event alarm rules set in the safety operation rules; controlling the display of the target abnormal event with the highest priority according to the alarm display priority; and obtaining alarm reminder information that matches the target abnormal event in the safety operation rules.

[0088] In practice, the operating status and output data of blood glucose monitoring devices and insulin infusion devices can be continuously monitored through set safety operation rules to identify any abnormal events. For example, if the real-time blood glucose value of the blood glucose monitoring device exceeds a set threshold (e.g., ≥10.0 mmol / L), or if the insulin infusion device malfunctions (e.g., infusion interruption), it is considered an abnormal event. When an abnormal event is identified, the alarm display priority for each type of event is determined according to preset abnormal event alarm rules. Specifically, a priority list can be maintained, in which the alarm display priority for each type of abnormal event is set. When multiple abnormal events occur simultaneously, the event with the highest alarm display priority is identified as the target abnormal event. The alarm reminder information corresponding to the target abnormal event in the safety operation rules is retrieved and displayed in the alarm display area.

[0089] In some embodiments, alarm notifications may be presented through at least one of visual cues, sound cues, or text cues. For example, a high blood sugar alarm might include the following message: "The patient's blood sugar is too high; please check the insulin infusion immediately."

[0090] In some embodiments, the higher the alarm display priority, the more the alarm notification information can be presented. For example, for a high priority level, the alarm display area is set to red; for a medium priority level, the alarm display area is set to yellow, and so on. Furthermore, different audio can be set for different alarm display priorities; for example, higher priorities can use high-frequency sounds, while lower priorities can use lower-frequency alert sounds, and so on.

[0091] In this embodiment, by implementing clear priority management, the most urgent abnormal events can be handled first. This priority management avoids information overload, enabling medical staff to allocate attention and resources efficiently and optimizing nursing efficiency.

[0092] Furthermore, in an exemplary embodiment, determining the alarm display priority of an abnormal event according to the abnormal event alarm rules set by the safe operation rules includes: formulating the alarm level and priority number of the abnormal event according to the safe operation rules; identifying the event content of the abnormal event, obtaining the alarm level and priority number of the abnormal event according to the event content; and determining the alarm display priority of the abnormal event according to the alarm level and priority number.

[0093] In practical implementation, a set of safe operation rules can be established in the system, which are formulated according to actual needs. Based on different types of abnormal events (such as hyperglycemia, hypoglycemia, equipment failure, etc.), an alarm level (e.g., "high", "medium", "low") and a priority number (e.g., 1, 2, 3) are defined for each event. Different alarm levels correspond to different thresholds, for example:

[0094] High alarm level (1): Blood glucose level ≥13.0 mmol / L or ≤3.0 mmol / L, requires immediate action.

[0095] Medium alarm level (2): Blood glucose levels between 10.0 mmol / L and 12.9 mmol / L require monitoring.

[0096] Low alarm level (3): Blood glucose levels are between 4.0 mmol / L and 9.9 mmol / L, requiring no immediate action.

[0097] Both the blood glucose monitoring device and the insulin infusion device can handle multiple abnormal events. Each abnormal event under the blood glucose monitoring device can be set with low, medium, and high alarm levels, and each can be assigned a priority number. Similarly, each abnormal event under the insulin infusion device can be set with low, medium, and high alarm levels, and each can be assigned a priority number. The alarm display priority for abnormal events is determined based on both the alarm level and the priority number. Alternatively, the alarm display priority can be determined first based on the alarm level; if the alarm display priorities are the same, then the priority number can be used to determine the alarm display priority. The specific settings can be configured according to actual needs, and this application does not impose specific limitations on this.

[0098] In this embodiment, the alarm display priority of abnormal events is determined by comprehensively considering alarm levels and priority numbers. This enables accurate identification and classification of various abnormal events, effectively improving the accuracy and responsiveness of the blood glucose monitoring system and ensuring that medical personnel can focus on the most urgent issues and take timely intervention measures.

[0099] In one exemplary embodiment, after controlling the display of the highest priority target abnormal event according to the alarm display priority, the method further includes: in response to an alarm reset operation performed by the user, performing an alarm reset operation on the highest priority target abnormal event; and after the reset is completed, displaying alarm reminder information of the second highest priority abnormal event according to the alarm display priority.

[0100] Specifically, after displaying the highest-priority target abnormal event based on alarm display priority, medical staff can handle this target abnormal event. Once resolved, an alarm reset operation can be performed, for example, via the reset button or reset option on the display interface. Upon detecting this operation, the system can reset the alarm for the highest-priority target abnormal event, such as clearing its current alarm status, marking it as handled, and recording the reset time for later review. After the reset operation, the system can reassess the current list of abnormal events, determine the next highest-priority event as the new target abnormal event, obtain the corresponding alarm notification information for the new target abnormal event, and display it in the alarm display area. This process continues, allowing for the sequential handling of each abnormal event according to its alarm display priority from highest to lowest.

[0101] In this embodiment, an alarm reset operation is set to eliminate the alarm for the highest priority target abnormal event, and alarm reminder information for the second highest priority abnormal event is displayed according to the alarm display priority, thereby realizing the orderly processing of each abnormal event according to the alarm display priority.

[0102] In one embodiment, the method further includes: if the display type of the alarm notification information of the target abnormal event is the immediate display type or the alarm display priority of the target abnormal event is not lower than the alarm display priority of the currently displayed abnormal event, then stop the alarm notification information of the currently displayed abnormal event and display the alarm notification information of the target abnormal event.

[0103] Specifically, if an alarm notification is currently displayed in the alarm display area, before displaying the alarm notification for the target abnormal event, the alarm display priority of the currently displayed abnormal event can be determined and compared with the alarm display priority of the target abnormal event. If the alarm display priority of the target abnormal event is higher than that of the currently displayed abnormal event, or if the display type of the alarm notification for the target abnormal event is immediate, then the alarm notification for the currently displayed abnormal event is stopped, and the alarm notification for the target abnormal event is displayed instead. Otherwise, the alarm notification for the currently displayed abnormal event continues to be displayed, and the alarm notification for the target abnormal event is displayed only after the current abnormal event has been processed.

[0104] By implementing this alarm information switching mechanism, the system can dynamically respond to various abnormal events, prioritizing the display of more urgent situations, which greatly improves the efficiency of blood glucose monitoring and medical safety.

[0105] In an exemplary embodiment, after the alarm display area in the control display section displays alarm reminder information in step S250, the method further includes: in response to the user's single-bed observation command for the display section, controlling the display interface to display the single-bed observation interface; and in response to the statistical analysis operation triggered by the user, controlling the single-bed observation interface to display statistical information of the patient's blood glucose measurement value and / or statistical information of insulin infusion information.

[0106] Specifically, when the system detects a user's single-bed observation command for a display segment, such as clicking on a display segment, it will switch the display interface to the single-bed observation interface for that segment. The single-bed observation interface displays the patient's detailed blood glucose information. When the system receives a user-triggered statistical analysis operation, such as a trigger on a statistical analysis control, it can summarize the collected patient's measured blood glucose values ​​and insulin infusion information to generate statistical information. This statistical information will then be displayed on the single-bed observation interface, showing the patient's blood glucose measurement statistics and / or insulin infusion statistics. Examples include: the average and standard deviation of blood glucose measurements, the trend over the past 7 days, the cumulative number of insulin infusions, the average infusion volume, and the infusion effects at different times.

[0107] In some embodiments, statistical information on blood glucose measurements and / or insulin infusion information may be presented in the form of charts, tables, etc., so that medical staff can quickly understand the patient's blood glucose control and the effect of medication.

[0108] In this embodiment, the design of the single-bed observation interface enables medical staff to quickly access and grasp detailed patient information, reducing the time spent searching for and inputting information and improving work efficiency; through the display of statistical information, medical staff can make more accurate clinical judgments based on data.

[0109] Furthermore, in an exemplary embodiment, the method further includes: in response to a user-triggered statistical analysis operation, displaying multiple time period entries; and based on the user's selection instruction for a target time period entry among the multiple time period entries, controlling the single-bed observation interface to display statistical information on the patient's blood glucose measurement values ​​and / or insulin infusion information within the time period corresponding to the target time period entry.

[0110] Specifically, when a user-triggered statistical analysis operation is received, the single-bed observation interface can simultaneously display statistical information on the patient's blood glucose measurements and / or insulin infusion information. This can include multiple time period entries, such as "Past 24 Hours," "Past 7 Days," "Past 30 Days," and "Custom Time Period." Each time period entry can be a clickable option, allowing the user to select as needed. Upon detecting a user's selection command for any of the multiple time period entries, the single-bed observation interface displays the statistical information on the patient's blood glucose measurements and / or insulin infusion information for the corresponding time period. For example, if the user clicks "Past 7 Days," the single-bed observation interface will display the statistical information on the patient's blood glucose measurements and / or insulin infusion information for the past 7 days.

[0111] In this embodiment, by providing multiple time period entry points, users can flexibly select the analysis time range to meet different clinical needs and enhance the adaptability of data analysis.

[0112] It is understood that, in addition to monitoring for anomalies in blood glucose monitoring devices and insulin infusion devices, when data from blood glucose monitoring devices and insulin infusion devices is collected through the terminal, anomaly monitoring can also be performed on the terminal itself. Correspondingly, in an exemplary embodiment, such as... Figure 4 As shown, the method further includes:

[0113] Step S410: Receive and display the blood glucose monitoring value, blood glucose monitoring device information, insulin infusion information, and insulin infusion device information uploaded by the terminal associated with the patient corresponding to the display segment;

[0114] Step S420: Based on the blood glucose monitoring value, information from the blood glucose monitoring device, insulin infusion information, or information from the insulin infusion equipment, perform anomaly detection on the blood glucose monitoring device, insulin infusion equipment, terminal, remote monitoring equipment, and closed-loop information.

[0115] Step S430: When an abnormality is detected in the blood glucose monitoring device, insulin infusion device, terminal, remote monitoring device, or closed-loop information, obtain the alarm reminder information corresponding to the abnormal event.

[0116] Closed-loop information refers to the information associated with a closed loop that forms a cyclical relationship between the insulin infusion device, the patient's blood glucose level, and the blood glucose monitoring device.

[0117] Specifically, such as Figure 1As shown, the blood glucose monitoring system receives blood glucose monitoring values ​​and insulin infusion information collected by the terminal before uploading them. Furthermore, in addition to obtaining the patient's blood glucose information from the blood glucose monitoring device, the terminal also obtains the device information of the blood glucose monitoring device. Similarly, in addition to obtaining the patient's insulin infusion information from the insulin infusion device, the terminal also obtains the device information of the insulin infusion device. Further, after obtaining this information, the blood glucose monitoring system can detect whether there are any abnormalities in the blood glucose monitoring device, insulin infusion device, terminal, remote monitoring device, and closed-loop information. If any abnormality is detected, an abnormality prompt message will be displayed in the alarm display area, and an audible alarm will be triggered simultaneously.

[0118] In some embodiments, the third area can be set in the upper right corner of the display area, and the abnormal prompt information can include text information, graphic information, sound information, etc., specifying the object of the abnormality and reflecting the reason for the abnormality.

[0119] Furthermore, in some embodiments, in step S430 above, when at least two abnormal events are detected in the blood glucose monitoring device, insulin infusion device, terminal, remote monitoring device, or closed-loop information, the alarm display priority order of each abnormal event is determined according to the alarm level and priority number of each abnormal event; the alarm reminder information of the abnormal event with the highest alarm display priority is displayed in the alarm display area. After receiving an alarm reset operation for the abnormal event with the highest alarm display priority, the alarm reminder information of the abnormal event with the second highest alarm display priority is displayed in the alarm display area, and so on.

[0120] In practical implementation, each object can have multiple possible causes for anomalies. For example, the causes of an insulin infusion device anomalies may include: excessively strong magnetic field in the pump environment, depleted pump power, depleted pump medication, blocked pump tubing, low battery, minimum dosage alarm status and value, and inability to connect the pump. The causes of a blood glucose monitoring device anomalies may include: hypoglycemia, hyperglycemia, rapid rise in blood glucose, rapid drop in blood glucose, lost blood glucose data, abnormal blood glucose data, sensor malfunction, and expired sensor. The causes of a terminal anomalies may include: storage space limitations, wireless connection status (success or failure), lack of storage permissions, and lack of location permissions. The causes of a remote monitoring device anomalies may include: remote connection anomalies, unsupported remote version, and lack of write permissions for the remote version (incorrect server address configuration). The causes of closed-loop information anomalies may include: failure to enable / disable automatic mode, failure to enable / disable automatic meal assistance mode, failure to enable / disable automatic temporary target blood glucose, failure to execute high-dose administration, failure to update algorithm parameters, and success / failure to set the basal rate.

[0121] In this embodiment, considering that the space of each display segment is limited and cannot display too many alarm reminders, when at least two abnormal events are detected in the blood glucose monitoring device, insulin infusion device, terminal, remote monitoring device or closed-loop information, the alarm prompt priority of each abnormal event is determined, and the abnormal event with the highest priority is selected to provide an abnormal prompt, thereby ensuring that the most urgent and most concerning abnormal information is processed first, thereby reducing potential risks.

[0122] In an exemplary embodiment, the method further includes: identifying blood glucose monitoring values, information from blood glucose monitoring devices, insulin infusion information, or information from insulin infusion equipment using a pre-trained anomaly recognition model, and determining abnormal results for blood glucose monitoring devices, insulin infusion equipment, terminals, remote monitoring devices, and closed-loop information.

[0123] In practice, abnormal data from various objects such as blood glucose monitoring devices, insulin infusion devices, terminals, remote monitoring devices, and closed-loop information can be collected in advance through the terminal to obtain an abnormal dataset, which is then uploaded to the blood glucose monitoring system. In the blood glucose monitoring system, the abnormal dataset is used to train the initial abnormal model to obtain a pre-trained abnormal identification model.

[0124] In one implementation, since there are multiple objects such as blood glucose monitoring devices, insulin infusion devices, terminals, remote monitoring devices, and closed-loop information, an anomaly recognition model can be trained for each object using the object's anomaly dataset, resulting in multiple anomaly recognition models.

[0125] In this embodiment, anomaly identification can be performed on blood glucose monitoring devices, insulin infusion devices, terminals, remote monitoring devices, and closed-loop information by using a pre-trained anomaly identification model, which can improve the accuracy and efficiency of anomaly identification.

[0126] In one implementation, user behavior can also be collected, including operational behaviors on the insulin infusion device, on the terminal app, on the blood glucose monitoring device, and remote monitoring behaviors. In-pump operational behaviors may include: settings, bolus dose, basal rate, historical records, finger-prick calibration, etc.; app operational behaviors may include: real-time monitoring, calculator, bolus dose, finger-prick input, my profile, alarm settings, reminder settings, caregiver, event check-in, sensor information, weight, algorithm parameters, help center; remote monitoring operational behaviors may include: multi-bed, single-bed, real-time monitoring, statistical analysis, treatment information, system settings, alarms, etc. These user behaviors are uploaded to a cloud-based big data server to build a user behavior dataset and train the system, generating user behavior reports. Based on these reports, improvements can be made to the design of the insulin infusion device, terminal app, blood glucose monitoring device, and remote monitoring device to facilitate user operation.

[0127] In one embodiment, to facilitate understanding of the embodiments of this application by those skilled in the art, specific examples will be described below in conjunction with the accompanying drawings.

[0128] refer to Figure 5 This is a schematic diagram of an interface for a single display segment, illustrating one embodiment. It includes a first area for displaying blood glucose changes, a second area for displaying insulin infusion records, and an alarm display area for displaying abnormal information from the blood glucose monitoring device, the insulin infusion device, the terminal, the remote monitoring device, and closed-loop information. Furthermore, each display segment also displays patient information corresponding to the patient, such as bed number, name, and diabetes type (type 1, type 2, etc.). Figure 5 The top left area is shown. It can also display the average blood glucose data, current basal rate / provisional basal rate, the record of the last high-dose insulin infusion, the dose of active insulin, etc.

[0129] For display segments that are not yet associated with any patients, a patient binding trigger operation can be performed to display the patient binding page. The patient binding page may include editing entry points for the patient's personal information, such as name, number, bed, diabetes type, etc. Editing operations can be performed on each editing entry point. After confirming the binding, the patient is bound to the display segment.

[0130] For a display segment that is already associated with a patient, the patient information associated with that display segment can be modified. Specifically, in response to the user's editing of the patient information, a patient information management page can be displayed. This patient information management page may include an entry point for editing the patient's personal information, allowing users to edit the patient information through this entry point.

[0131] The blood glucose monitoring system's display interface also allows for alarm settings, including enabling / disabling different alarm conditions and setting alarm thresholds (e.g., extremely low blood glucose alarm threshold, low blood glucose alarm threshold, high blood glucose alarm threshold, blood glucose loss alarm threshold, low medication dosage alarm threshold, etc.), as well as setting alarm methods, including different alarm levels, such as minimum alarm volume, alarm sound, high alarm tone interval, medium alarm tone interval, low alarm tone interval, alarm sound type, etc. It also provides alarm reset and alarm pause functions, allowing users to clear alarms after handling them using the alarm reset control, or pause alarms during the handling process using the alarm pause control.

[0132] The blood glucose monitoring system can also perform statistical analysis on the blood glucose monitoring data of patients in each display segment. When it receives a blood glucose statistical analysis command for a patient corresponding to a certain display segment, it can display the statistical analysis results interface. The statistical analysis results interface can include a discrete plot of blood glucose data, a bar chart of insulin infusion records, basal rate records, average blood glucose values, etc. It can also view the percentage of time a patient's blood glucose is within the normal range, the percentage of time above the upper limit of the normal range, and the percentage of time below the lower limit of the normal range within the statistical period. It can also view the patient's daily total insulin injection, total carbohydrate intake, basal rate, and maximal dose percentages, as well as the percentage of time in manual and automatic modes within the statistical period. This data can be displayed in the form of progress bars, tables, and other charts. The statistical analysis results page can also display terminal battery level, insulin infusion device connection duration, remaining days of the blood glucose monitoring device, etc. It also provides statistical analysis functions for different time ranges (e.g., the last two days, the last week, the last month, etc.), allowing for both single-day viewing and multi-day statistics. In addition, the blood glucose monitoring system provides functions for sharing and exporting patient blood glucose monitoring data.

[0133] It should be understood that although the steps in the flowcharts of the embodiments described above are shown sequentially according to the arrows, these steps are not necessarily executed in the order indicated by the arrows. Unless explicitly stated herein, there is no strict order restriction on the execution of these steps, and they can be executed in other orders. Moreover, at least some steps in the flowcharts of the embodiments described above may include multiple steps or multiple stages. These steps or stages are not necessarily completed at the same time, but can be executed at different times. The execution order of these steps or stages is not necessarily sequential, but can be performed alternately or in turn with other steps or at least some of the steps or stages of other steps.

[0134] Based on the same inventive concept, this application also provides a blood glucose monitoring system for implementing the interface display method described above. The solution provided in this system diagram is similar to the implementation described in the above method; therefore, the specific limitations in one or more blood glucose monitoring system embodiments provided below can be found in the limitations of the interface display method described above, and will not be repeated here.

[0135] In one embodiment, such as Figure 6As shown, a blood glucose monitoring system is provided, including a blood glucose monitoring device 610, an insulin infusion device 620, a display device 630, a communication unit 640, and at least one processor 650, the processor being configured to execute executable instructions on a memory to implement the method as described in any of the above embodiments.

[0136] In one embodiment, a computer device is provided, which may be a terminal, and its internal structure diagram may be as follows: Figure 7 As shown, the computer device includes a processor, memory, communication interface, display screen, and input devices connected via a system bus. The processor provides computing and control capabilities. The memory includes non-volatile storage media and internal memory. The non-volatile storage media stores the operating system and computer programs. The internal memory provides an environment for the operation of the operating system and computer programs stored in the non-volatile storage media. The communication interface is used for wired or wireless communication with external terminals; wireless communication can be achieved through Wi-Fi, mobile cellular networks, NFC (Near Field Communication), or other technologies. When the computer program is executed by the processor, it implements an interface display method. The display screen can be an LCD screen or an e-ink screen. The input devices can be a touch layer covering the display screen, buttons, a trackball, or a touchpad located on the computer device's casing, or an external keyboard, touchpad, or mouse.

[0137] Those skilled in the art will understand that Figure 7 The structure shown is merely a block diagram of a portion of the structure related to the present application and does not constitute a limitation on the computer device to which the present application is applied. Specific computer devices may include more or fewer components than those shown in the figure, or combine certain components, or have different component arrangements.

[0138] In one embodiment, a computer device is also provided, including a memory and a processor, wherein the memory stores a computer program, and the processor executes the computer program to implement the steps in the above method embodiments.

[0139] In one embodiment, a computer-readable storage medium is provided having a computer program stored thereon that, when executed by a processor, implements the steps in the above method embodiments.

[0140] In one embodiment, a computer program product is provided, including a computer program that, when executed by a processor, implements the steps in the above method embodiments.

[0141] It should be noted that the user information (including but not limited to user device information, user personal information, etc.) and data (including but not limited to data used for analysis, data stored, data displayed, etc.) involved in this application are all information and data authorized by the user or fully authorized by all parties, and the collection, use and processing of related data must comply with the relevant laws, regulations and standards of the relevant countries and regions.

[0142] Those skilled in the art will understand that all or part of the processes in the above embodiments can be implemented by a computer program instructing related hardware. The computer program can be stored in a non-volatile computer-readable storage medium. When executed, the computer program can include the processes of the embodiments described above. Any references to memory, databases, or other media used in the embodiments provided in this application can include at least one of non-volatile and volatile memory. Non-volatile memory can include read-only memory (ROM), magnetic tape, floppy disk, flash memory, optical memory, high-density embedded non-volatile memory, resistive random access memory (ReRAM), magnetic random access memory (MRAM), ferroelectric random access memory (FRAM), phase change memory (PCM), graphene memory, etc. Volatile memory can include random access memory (RAM) or external cache memory, etc. By way of illustration and not limitation, RAM can take many forms, such as Static Random Access Memory (SRAM) or Dynamic Random Access Memory (DRAM). The databases involved in the embodiments provided in this application may include at least one type of relational database and non-relational database. Non-relational databases may include, but are not limited to, blockchain-based distributed databases. The processors involved in the embodiments provided in this application may be general-purpose processors, central processing units, graphics processing units, digital signal processors, programmable logic devices, quantum computing-based data processing logic devices, etc., and are not limited to these.

[0143] The technical features of the above embodiments can be combined in any way. For the sake of brevity, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0144] The embodiments described above are merely illustrative of several implementation methods of this application, and while the descriptions are specific and detailed, they should not be construed as limiting the scope of this patent application. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of this application, and these all fall within the protection scope of this application. Therefore, the protection scope of this application should be determined by the appended claims.

Claims

1. A method for displaying an interface, characterized in that, The method is applied to a blood glucose monitoring system, wherein the blood glucose monitoring system establishes communication connections with a blood glucose monitoring device and an insulin infusion device, respectively; the method includes: In response to the user's input command for a multi-bed observation mode, the display interface of the blood glucose monitoring system is controlled to display multiple display segments; After each display segment completes the device binding operation with the blood glucose monitoring device and the insulin infusion device, the information display area in the display segment is controlled to display the blood glucose measurement values ​​collected during the operation of the blood glucose monitoring device and the insulin infusion information implemented during the operation of the insulin infusion device; Monitor whether at least one abnormal event occurs during the operation of the blood glucose monitoring device and / or insulin infusion device; In the event of at least one abnormal event, obtain the alarm notification information to be displayed according to the abnormal event alarm rules; The alarm display area in the display section is controlled to display the alarm reminder information.

2. The interface display method according to claim 1, characterized in that, The step of obtaining alarm notification information according to the abnormal event alarm rules includes: The system identifies whether an abnormal event has occurred based on the safety operation rules of the blood glucose monitoring device and / or insulin infusion device; if an abnormal event is confirmed, the alarm display priority of the abnormal event is determined according to the abnormal event alarm rules set in the safety operation rules. Based on the alarm display priority, the highest priority target abnormal event is displayed; Obtain alarm notifications that match the target abnormal event from the safety operation rules.

3. The interface display method according to claim 2, characterized in that, Based on the abnormal event alarm rules set in the aforementioned safe operation rules, the alarm display priority for abnormal events is determined, including: Establish alarm levels and priority numbers for abnormal events according to safe operation rules; Identify the event content of the abnormal event, and obtain the alarm level and priority number of the abnormal event based on the event content; The alarm display priority of abnormal events is determined based on the alarm level and the priority number.

4. The interface display method according to claim 2, characterized in that, The method further includes: If the display type of the alarm notification information for the target abnormal event is the immediate display type, or the alarm display priority of the target abnormal event is not lower than the alarm display priority of the currently displayed abnormal event, then the alarm notification information for the currently displayed abnormal event is stopped, and the alarm notification information for the target abnormal event is displayed.

5. The interface display method according to claim 1, characterized in that, After the alarm display area in the control section displays the alarm reminder information, the method further includes: In response to the user's single-bed observation command for the display section, the display interface is controlled to display the single-bed observation interface; In response to the statistical analysis operation triggered by the user, the single-bed observation interface is controlled to display statistical information on the patient's blood glucose measurement and / or insulin infusion information.

6. The interface display method according to claim 5, characterized in that, The method further includes: In response to the statistical analysis operation triggered by the user, multiple time period entries are displayed; Based on the user's selection instruction for the target time period among the multiple time period entries, the single-bed observation interface is controlled to display statistical information on the patient's blood glucose measurement value and / or insulin infusion information within the time period corresponding to the target time period entry.

7. A blood glucose monitoring system, characterized in that, The device includes a blood glucose monitoring device, an insulin infusion device, a display device, a communication unit, and at least one processor, the processor being configured to execute executable instructions in a memory to implement the method as described in any one of claims 1 to 6.

8. A central station, characterized in that, It includes a display device, a communication unit, and at least one processor, the processor being configured to execute executable instructions in a memory to implement the method as described in any one of claims 1 to 6.

9. A computer-readable storage medium having a computer program stored thereon, characterized in that, When the computer program is executed by the processor, it implements the steps of the interface display method according to any one of claims 1 to 6.

10. A computer program product, comprising a computer program, characterized in that, When the computer program is executed by a processor, it implements the steps of the interface display method according to any one of claims 1 to 6.

Images